Literature DB >> 31791173

The impact of proline isomerization on antigen binding and the analytical profile of a trispecific anti-HIV antibody.

Alessandro Masiero1, Lechat Nelly2, Gentric Marianne2, Sourrouille Christophe2, Laville Florian2, Crépin Ronan2, Borel Claire2, Ziegler Cornelia2, Bisch Grégoire2, Leclerc Eric2, Laurent Ludovic2, Brault Dominique2, Alexandre Sylvie2, Gagnaire Marie1, Duffieux Francis1, Soubrier Fabienne1, Capdevila Cécile1, Arnould Isabelle1, Dumas Jacques1, Dabin Jérôme2, Genet Bruno2, Radošević Katarina1, Menet Jean-Michel2, Prades Catherine1.   

Abstract

Proline cis-trans conformational isomerization is a mechanism that affects different types of protein functions and behaviors. Using analytical characterization, structural analysis, and molecular dynamics simulations, we studied the causes of an aberrant two-peak size-exclusion chromatography profile observed for a trispecific anti-HIV antibody. We found that proline isomerization in the tyrosine-proline-proline (YPP) motif in the heavy chain complementarity-determining region (CDR)3 domain of one of the antibody arms (10e8v4) was a component of this profile. The pH effect on the conformational equilibrium that led to these two populations was presumably caused by a histidine residue (H147) in the light chain that is in direct contact with the YPP motif. Finally, we demonstrated that, due to chemical equilibrium between the cis and trans proline conformers, the antigen-binding potency of the trispecific anti-HIV antibody was not significantly affected in spite of a potential structural clash of 10e8v4 YPtransPtrans conformers with the membrane-proximal ectodomain region epitope in the GP41 antigen. Altogether, these results reveal at mechanistic and molecular levels the effect of proline isomerization in the CDR on the antibody binding and analytical profiles, and support further development of the trispecific anti-HIV antibody.

Entities:  

Keywords:  Proline isomerization; antibody conformers; chemical equilibrium; developability

Mesh:

Substances:

Year:  2020        PMID: 31791173      PMCID: PMC8675452          DOI: 10.1080/19420862.2019.1698128

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  43 in total

1.  Prolyl cis-trans Isomerization as a molecular timer in Crk signaling.

Authors:  Linda K Nicholson; Kun Ping Lu
Journal:  Mol Cell       Date:  2007-02-23       Impact factor: 17.970

2.  VMD: visual molecular dynamics.

Authors:  W Humphrey; A Dalke; K Schulten
Journal:  J Mol Graph       Date:  1996-02

3.  Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex.

Authors:  Devin Sok; Marit J van Gils; Matthias Pauthner; Jean-Philippe Julien; Karen L Saye-Francisco; Jessica Hsueh; Bryan Briney; Jeong Hyun Lee; Khoa M Le; Peter S Lee; Yuanzi Hua; Michael S Seaman; John P Moore; Andrew B Ward; Ian A Wilson; Rogier W Sanders; Dennis R Burton
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-24       Impact factor: 11.205

4.  Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1.

Authors:  Xueling Wu; Zhi-Yong Yang; Yuxing Li; Carl-Magnus Hogerkorp; William R Schief; Michael S Seaman; Tongqing Zhou; Stephen D Schmidt; Lan Wu; Ling Xu; Nancy S Longo; Krisha McKee; Sijy O'Dell; Mark K Louder; Diane L Wycuff; Yu Feng; Martha Nason; Nicole Doria-Rose; Mark Connors; Peter D Kwong; Mario Roederer; Richard T Wyatt; Gary J Nabel; John R Mascola
Journal:  Science       Date:  2010-07-08       Impact factor: 47.728

Review 5.  Insights into peptidyl-prolyl cis-trans isomerase structure and function in immunocytes.

Authors:  Pulak Ranjan Nath; Noah Isakov
Journal:  Immunol Lett       Date:  2014-11-13       Impact factor: 3.685

6.  Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor.

Authors:  Amarendra Pegu; Zhi-yong Yang; Jeffrey C Boyington; Lan Wu; Sung-Youl Ko; Stephen D Schmidt; Krisha McKee; Wing-Pui Kong; Wei Shi; Xuejun Chen; John-Paul Todd; Norman L Letvin; Jinghe Huang; Martha C Nason; James A Hoxie; Peter D Kwong; Mark Connors; Srinivas S Rao; John R Mascola; Gary J Nabel
Journal:  Sci Transl Med       Date:  2014-07-02       Impact factor: 17.956

7.  Side-chain effects on peptidyl-prolyl cis/trans isomerisation.

Authors:  U Reimer; G Scherer; M Drewello; S Kruber; M Schutkowski; G Fischer
Journal:  J Mol Biol       Date:  1998-06-05       Impact factor: 5.469

Review 8.  Prolyl isomerase Pin1: a promoter of cancer and a target for therapy.

Authors:  Yang Chen; Ya-Ran Wu; Hong-Ying Yang; Xin-Zhe Li; Meng-Meng Jie; Chang-Jiang Hu; Yu-Yun Wu; Shi-Ming Yang; Ying-Bin Yang
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

Review 9.  Immunoglobulin Gamma-Like Therapeutic Bispecific Antibody Formats for Tumor Therapy.

Authors:  Shixue Chen; Lingling Li; Fan Zhang; Yu Wang; Yi Hu; Lei Zhao
Journal:  J Immunol Res       Date:  2019-02-11       Impact factor: 4.818

10.  Integrating protein structural dynamics and evolutionary analysis with Bio3D.

Authors:  Lars Skjærven; Xin-Qiu Yao; Guido Scarabelli; Barry J Grant
Journal:  BMC Bioinformatics       Date:  2014-12-10       Impact factor: 3.169

View more
  2 in total

1.  Combination of IM-Based Approaches to Unravel the Coexistence of Two Conformers on a Therapeutic Multispecific mAb.

Authors:  Evolène Deslignière; Simon Ollivier; Anthony Ehkirch; Armelle Martelet; David Ropartz; Nelly Lechat; Oscar Hernandez-Alba; Jean-Michel Menet; Séverine Clavier; Hélène Rogniaux; Bruno Genet; Sarah Cianférani
Journal:  Anal Chem       Date:  2022-05-23       Impact factor: 8.008

2.  The influence of proline isomerization on potency and stability of anti-HIV antibody 10E8.

Authors:  Miklos Guttman; Neal N Padte; Yaoxing Huang; Jian Yu; Gabriel J Rocklin; Brian D Weitzner; Michele Scian; David D Ho; Kelly K Lee
Journal:  Sci Rep       Date:  2020-08-31       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.